Journal of Infection
Volume 60, Issue 5 , Pages 360-370 , May 2010

Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults

  • Juanhong Wang

      Affiliations

    • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, No. 17, Changle West Road, Xi’an 710032, PR China
    • Department of Pathology, Xi'an Central Hospital, Xi’an 710003, PR China
    • ,
  • Weiping Zhang

      Affiliations

    • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, No. 17, Changle West Road, Xi’an 710032, PR China
    • ,
  • Hongxiang Liu

      Affiliations

    • Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK
    • ,
  • Di Wang

      Affiliations

    • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, No. 17, Changle West Road, Xi’an 710032, PR China
    • ,
  • Wenqing Wang

      Affiliations

    • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, No. 17, Changle West Road, Xi’an 710032, PR China
    • ,
  • Yuanfei Li

      Affiliations

    • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, No. 17, Changle West Road, Xi’an 710032, PR China
    • ,
  • Zhe Wang

      Affiliations

    • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, No. 17, Changle West Road, Xi’an 710032, PR China
    • ,
  • Lu Wang

      Affiliations

    • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, No. 17, Changle West Road, Xi’an 710032, PR China
    • ,
  • Wei Zhang

      Affiliations

    • Department of Pathology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, PR China
    • ,
  • Gaosheng Huang

      Affiliations

    • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, No. 17, Changle West Road, Xi’an 710032, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 029 8477 4946; fax: +86 029 8325 5697.

,Accepted 7 February 2010.

References 

  1. Eto S. [Hashimoto disease]. Nippon Rinsho. 1999;57:1749–1754
  2. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348:2646–2655
  3. Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y, et al. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev. 2008;8:112–115
  4. Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6:5
  5. Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350:586–597
  6. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol. 1988;25:151–153
  7. Meyer O. Parvovirus B19 and autoimmune diseases. Joint Bone Spine. 2003;70:6–11
  8. Aktepe OC, Yetgin S, Olcay L, Ozbek N. Human parvovirus B19 associated with idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol. 2004;21:421–426
  9. Lehmann HW, Lutterbuse N, Plentz A, Akkurt I, Albers N, Hauffa BP, et al. Association of parvovirus B19 infection and Hashimoto's thyroiditis in children. Viral Immunol. 2008;21:379–383
  10. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, et al. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis. J Infect. 2007;55:e29–31
  11. Ozawa K, Ayub J, Kajigaya S, Shimada T, Young N. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol. 1988;62:2884–2889
  12. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol. 2004;53:459–475
  13. von Poblotzki A, Gerdes C, Reischl U, Wolf H, Modrow S. Lymphoproliferative responses after infection with human parvovirus B19. J Virol. 1996;70:7327–7330
  14. Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, et al. Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer. 2008;98:611–618
  15. Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol. 1996;70:8485–8491
  16. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7–11
  17. Zadori Z, Szelei J, Lacoste MC, Li Y, Gariepy S, Raymond P, et al. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell. 2001;1:291–302
  18. Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev. 2003;2:218–223
  19. Greer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol. 1991;95:117–124
  20. Bultmann BD, Klingel K, Sotlar K, Bock CT, Kandolf R. Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Arch. 2003;442:8–17
  21. Morey AL, Porter HJ, Keeling JW, Fleming KA. Non-isotopic in-situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection. J Clin Pathol. 1992;45:673–678
  22. Elias JM, Margiotta M, Gaborc D. Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol. 1989;92:62–67
  23. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A. 2006;103:7450–7453
  24. Munakata Y, Kodera T, Saito T, Sasaki T. Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus B19 infection. Lancet. 2005;366:780
  25. Mendelson E, Grossman Z, Mileguir F, Rechavi G, Carter BJ. Replication of adeno-associated virus type 2 in human lymphocytic cells and interaction with HIV-1. Virology. 1992;187:453–463
  26. Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis. 2000;59:672–683
  27. Wolter S, Richards R, Armentrout RW. Cell cycle-dependent replication of the DNA of minute virus of mice, a parvovirus. Biochim Biophys Acta. 1980;607:420–431
  28. Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions. J Pathol. 2002;198:157–162
  29. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med. 1994;330:1192–1196
  30. Rouger P, Gane P, Salmon C. Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies. Rev Fr Transfus Immunohematol. 1987;30:699–708
  31. Bouchon B, Portoukalian J, Bornet H. Alterations of the cerebroside fraction of human thyroid glycosphingolipids in Graves' disease. Biochem Int. 1985;11:415–424
  32. Dunstan RA. Status of major red cell blood group antigens on neutrophils, lymphocytes and monocytes. Br J Haematol. 1986;62:301–309
  33. Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, et al. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol. 2002;76:2014–2018
  34. Lu J, Zhi N, Wong S, Brown KE. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis. 2006;193:582–590
  35. Ajjan RA, Watson PF, McIntosh RS, Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol. 1996;105:523–528
  36. Lunardi C, Tiso M, Borgato L, Nanni L, Millo R, De Sandre G. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol. 1998;28:936–948
  37. Loizou S, Cazabon JK, Walport MJ, Tait D, So AK, et al. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 1997;40:103–108

PII: S0163-4453(10)00045-9

doi: 10.1016/j.jinf.2010.02.006

Journal of Infection
Volume 60, Issue 5 , Pages 360-370 , May 2010

Article Tools

* Image Usage & Resolution